280 related articles for article (PubMed ID: 31016376)
1. Pathologic and MRI analysis in acute atypical inflammatory demyelinating lesions.
Ayrignac X; Rigau V; Lhermitte B; Vincent T; de Champfleur NM; Carra-Dalliere C; Charif M; Collongues N; de Seze J; Hebbadj S; Ahle G; Oesterlé H; Cotton F; Durand-Dubief F; Marignier R; Vukusic S; Taithe F; Cohen M; Guennoc AM; Kerbrat A; Edan G; Carsin-Nicol B; Allou T; Sablot D; Thouvenot E; Ruet A; Magy L; Boncoeur-Martel MP; Labauge P; Kremer S
J Neurol; 2019 Jul; 266(7):1743-1755. PubMed ID: 31016376
[TBL] [Abstract][Full Text] [Related]
2. Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders.
Sechi E; Krecke KN; Messina SA; Buciuc M; Pittock SJ; Chen JJ; Weinshenker BG; Lopez-Chiriboga AS; Lucchinetti CF; Zalewski NL; Tillema JM; Kunchok A; Monaco S; Morris PP; Fryer JP; Nguyen A; Greenwood T; Syc-Mazurek SB; Keegan BM; Flanagan EP
Neurology; 2021 Sep; 97(11):e1097-e1109. PubMed ID: 34261784
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions.
Popescu BF; Guo Y; Jentoft ME; Parisi JE; Lennon VA; Pittock SJ; Weinshenker BG; Wingerchuk DM; Giannini C; Metz I; Brück W; Shuster EA; Carter J; Boyd CD; Clardy SL; Cohen BA; Lucchinetti CF
Neurology; 2015 Jan; 84(2):148-58. PubMed ID: 25503621
[TBL] [Abstract][Full Text] [Related]
4. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic algorithm for relapsing acquired demyelinating syndromes in children.
Hacohen Y; Mankad K; Chong WK; Barkhof F; Vincent A; Lim M; Wassmer E; Ciccarelli O; Hemingway C
Neurology; 2017 Jul; 89(3):269-278. PubMed ID: 28615429
[TBL] [Abstract][Full Text] [Related]
6. [The correlation factor analysis for conversion of clinically isolated syndrome to multiple sclerosis and neuromyelitis optica].
Bi CF; Qian HR; Peng LJ; Mao LL; Huang X; Xia DY; Lei X; Qi XK
Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):460-5. PubMed ID: 27256609
[TBL] [Abstract][Full Text] [Related]
7. [Recent progress in multiple sclerosis research: astrocytopathy in demyelinating diseases].
Kira J
Rinsho Shinkeigaku; 2010 Nov; 50(11):788-93. PubMed ID: 21921443
[TBL] [Abstract][Full Text] [Related]
8. Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.
Jurynczyk M; Geraldes R; Probert F; Woodhall MR; Waters P; Tackley G; DeLuca G; Chandratre S; Leite MI; Vincent A; Palace J
Brain; 2017 Mar; 140(3):617-627. PubMed ID: 28364548
[TBL] [Abstract][Full Text] [Related]
9. Callosal lesions on magnetic resonance imaging with multiple sclerosis, neuromyelitis optica spectrum disorder and acute disseminated encephalomyelitis.
Cai MT; Zhang YX; Zheng Y; Fang W; Ding MP
Mult Scler Relat Disord; 2019 Jul; 32():41-45. PubMed ID: 31030018
[TBL] [Abstract][Full Text] [Related]
10. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
[TBL] [Abstract][Full Text] [Related]
11. Hypothalamic abnormality in patients with inflammatory demyelinating disorders.
Gao C; Wu L; Chen X; Long Y; Zhong R; Yang N; Chen Y
Int J Neurosci; 2016 Nov; 126(11):1036-43. PubMed ID: 26514655
[TBL] [Abstract][Full Text] [Related]
12. Atypical idiopathic inflammatory demyelinating lesions (IIDL): conventional and diffusion-weighted MR imaging (DWI) findings in 42 cases.
Koelblinger C; Fruehwald-Pallamar J; Kubin K; Wallner-Blazek M; van den Hauwe L; Macedo L; Puchner SB; Thurnher MM
Eur J Radiol; 2013 Nov; 82(11):1996-2004. PubMed ID: 23993757
[TBL] [Abstract][Full Text] [Related]
13. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium enhancement patterns of tumefactive demyelinating lesions: correlations with brain biopsy findings and pathophysiology.
Kobayashi M; Shimizu Y; Shibata N; Uchiyama S
J Neurol; 2014 Oct; 261(10):1902-10. PubMed ID: 25034274
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis and neuromyelitis optica spectrum disorders in Malaysia: A comparison in different ethnic groups.
Viswanathan S; Rose N; Arip M; Chai CH; Law WC; Sim R; Ong MC
Mult Scler Relat Disord; 2018 Oct; 25():300-308. PubMed ID: 30172173
[TBL] [Abstract][Full Text] [Related]
16. [The clinical features, neuroimaging findings and pathological characteristics of 26 patients with pathologically proven tumor-like inflammatory demyelinating diseases].
Qi XK; Liu JG; Qian HR; Qiu F; Yao S; Li CQ; Wang YM
Zhonghua Nei Ke Za Zhi; 2010 Sep; 49(9):750-3. PubMed ID: 21092444
[TBL] [Abstract][Full Text] [Related]
17. Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese.
Chan KH; Lee R; Lee JC; Tse AC; Pang SY; Lau GK; Teo KC; Ho PW
J Neuroimmunol; 2013 Sep; 262(1-2):100-5. PubMed ID: 23838529
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of the spectrum of demyelinating disease in Western Australia.
Wu JS; Zhang MN; Carroll WM; Kermode AG
J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1022-6. PubMed ID: 18356258
[TBL] [Abstract][Full Text] [Related]
19. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
[TBL] [Abstract][Full Text] [Related]
20. Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate.
Brück W; Popescu B; Lucchinetti CF; Markovic-Plese S; Gold R; Thal DR; Metz I
Ann Neurol; 2012 Sep; 72(3):385-94. PubMed ID: 23034911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
